热门资讯> 正文
2023-04-04 16:02
Alliance Global Partners lowered shares of Heska (NASDAQ:HSKA – Get Rating) from a buy rating to a neutral rating in a research report released on Monday, The Fly reports.
Other equities research analysts also recently issued research reports about the stock. StockNews.com assumed coverage on shares of Heska in a research note on Thursday, March 16th. They set a hold rating on the stock. Morgan Stanley cut Heska from an equal weight rating to an underweight rating and set a $58.00 target price for the company. in a report on Friday, January 6th. Finally, Piper Sandler cut their target price on Heska from $165.00 to $150.00 in a research report on Thursday, March 2nd. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, Heska has a consensus rating of Hold and an average price target of $121.75.
Get Heska alerts:Shares of Heska stock opened at $117.74 on Monday. Heska has a 1 year low of $57.83 and a 1 year high of $149.17. The company's fifty day simple moving average is $87.16 and its 200-day simple moving average is $75.85. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -61.00 and a beta of 1.53. The company has a current ratio of 6.70, a quick ratio of 5.18 and a debt-to-equity ratio of 0.23.
In other news, CEO Kevin S. Wilson acquired 11,018 shares of the firm's stock in a transaction on Friday, January 6th. The shares were purchased at an average cost of $58.62 per share, for a total transaction of $645,875.16. Following the transaction, the chief executive officer now owns 167,072 shares of the company's stock, valued at $9,793,760.64. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 11.00% of the stock is owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Synovus Financial Corp boosted its position in shares of Heska by 3.0% during the third quarter. Synovus Financial Corp now owns 5,355 shares of the medical research company's stock worth $392,000 after purchasing an additional 156 shares in the last quarter. Wrapmanager Inc. raised its holdings in Heska by 3.9% during the 4th quarter. Wrapmanager Inc. now owns 4,297 shares of the medical research company's stock worth $267,000 after buying an additional 162 shares during the period. Mutual of America Capital Management LLC raised its holdings in shares of Heska by 11.7% during the third quarter. Mutual of America Capital Management LLC now owns 2,024 shares of the medical research company's stock worth $148,000 after acquiring an additional 212 shares during the period. Signaturefd LLC boosted its stake in Heska by 146.3% in the 4th quarter. Signaturefd LLC now owns 399 shares of the medical research company's stock worth $25,000 after purchasing an additional 237 shares during the period. Finally, PNC Financial Services Group Inc. increased its holdings in Heska by 18.5% during the 4th quarter. PNC Financial Services Group Inc. now owns 1,673 shares of the medical research company's stock worth $104,000 after purchasing an additional 261 shares in the last quarter. Institutional investors own 99.01% of the company's stock.
(Get Rating)
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland.
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.